The finding that DHRS7 is able to inactivate 5α-DHT, the most potent AR ligand in men [3,7], to 3α-Adiol led to the hypothesis that DHRS7 acts as a tumor-suppressor in PCa by lowering intratumoral 5α-DHT levels [15]. Here, DHRS7 is linked to neoplasm.